Sarepta Therapeutics Inc (SRPT) — Cash Flow Quality Index
Sarepta Therapeutics Inc (SRPT) has a Cash Flow Quality Index of -0.02x as of June 2026. Operating cash flow of $-5.61 Million is below net income of $326.07 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Sarepta Therapeutics Inc (SRPT) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Sarepta Therapeutics Inc Cash Flow Quality Index (2024–2024)
Historical Cash Flow Quality Index for Sarepta Therapeutics Inc across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see Sarepta Therapeutics Inc operating cash flow efficiency.
Annual Cash Flow Quality Index for Sarepta Therapeutics Inc (2024–2024)
Year-by-year earnings quality comparison for Sarepta Therapeutics Inc.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | -0.87x | $-205.79 Million | $235.24 Million | — |